Início › Câncer Metastático › Kentucky › Lexington
Ensaios clínicos de Câncer Metastático em Lexington, KY
11 estudos para Câncer Metastático estão buscando participantes em locais em Lexington e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
RecrutandoFase 1
- University of Kentucky/Markey Cancer Center, Lexington
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecrutandoFase 2/3
- University of Kentucky Markey Cancer Center, Lexington
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecrutandoFase 3
- Baptist Health Lexington, Lexington
- Baptist Health Richmond, Lexington
- Baptist Health Hamburg, Lexington
- e mais 3
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecrutandoFase 2/3
- University of Kentucky Research Foundation, Lexington
- University of Kentucky Healthcare - Markey Cancer Center, Lexington
- University of Kentucky Medical Center, Lexington
- e mais 1
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecrutandoFase 3
- Baptist Health Lexington, Lexington
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecrutandoFase 3
- CHI Saint Joseph Cancer Center - East, Lexington
- University of Kentucky Chandler Medical Center, Lexington
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
RecrutandoFase 2
- University of Kentucky/Markey Cancer Center, Lexington
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RecrutandoFase 1/2
- Crinetics Study Site, Lexington
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
RecrutandoFase 1
- UK Markey Cancer Center, Lexington
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RecrutandoFase 1
- University of Kentucky Markey Cancer Center, Lexington
Ensaios de Câncer Metastático em outras cidades
- Houston, TX104 estudos
- New York City, NY93 estudos
- Nashville, TN70 estudos
- Boston, MA63 estudos
- Los Angeles, CA57 estudos
- St. Louis, MO54 estudos
- Arlington, VA53 estudos
- Philadelphia, PA46 estudos
- Chicago, IL45 estudos
- San Antonio, TX44 estudos
- Washington, DC43 estudos
- Dallas, TX42 estudos
Outros estudos em Lexington
- Câncer de Pulmão de Não Pequenas Células23 estudos
- Câncer de Pulmão18 estudos
- Câncer de Ovário16 estudos
- Câncer de Próstata14 estudos
- Câncer (todos os tipos)14 estudos
- Câncer de Mama14 estudos
- Câncer Colorretal11 estudos
- Insuficiência Cardíaca11 estudos
- Melanoma10 estudos
- Leucemia Mieloide Aguda10 estudos
- Obesidade10 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço9 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.